<?xml version="1.0" encoding="UTF-8"?>
<gtr:projectOverview xmlns:gtr="http://gtr.ukri.org/api"><gtr:projectComposition><gtr:collaborations><gtr:collaborator url="http://gtr.ukri.org:80/organisation/CF11C8EB-DE92-4FC8-8F5D-477390597C44"><gtr:id>CF11C8EB-DE92-4FC8-8F5D-477390597C44</gtr:id><gtr:name>McMaster University</gtr:name><gtr:address><gtr:line1>1280 Main Street West</gtr:line1><gtr:line4>Hamilton, Ontario</gtr:line4><gtr:line5>L8S 4L8</gtr:line5><gtr:region>Outside UK</gtr:region><gtr:country>Canada</gtr:country></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/51A751AB-38DA-40F0-9408-10E24875FEBA"><gtr:id>51A751AB-38DA-40F0-9408-10E24875FEBA</gtr:id><gtr:name>Christchurch Hospital</gtr:name></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/4A179E2C-FB5E-4836-AA80-6301F4DD5AB6"><gtr:id>4A179E2C-FB5E-4836-AA80-6301F4DD5AB6</gtr:id><gtr:name>University of Sydney</gtr:name><gtr:address><gtr:line1>University of Sydney</gtr:line1><gtr:region>Outside UK</gtr:region><gtr:country>Australia</gtr:country></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/1DED8BE4-FAAC-4D4F-B5D8-20D587078DF4"><gtr:id>1DED8BE4-FAAC-4D4F-B5D8-20D587078DF4</gtr:id><gtr:name>Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)</gtr:name></gtr:collaborator></gtr:collaborations><gtr:leadResearchOrganisation url="http://gtr.ukri.org:80/organisation/3EAE04CA-9D62-4483-B9C4-F91AD9F4C5A9"><gtr:id>3EAE04CA-9D62-4483-B9C4-F91AD9F4C5A9</gtr:id><gtr:name>University of Oxford</gtr:name><gtr:department>National Perinatal Epidemiology Unit</gtr:department><gtr:address><gtr:line1>University Chest</gtr:line1><gtr:line2>Wellington Square</gtr:line2><gtr:line4>Oxford</gtr:line4><gtr:postCode>OX1 2JD</gtr:postCode><gtr:region>South East</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:typeInd>RO</gtr:typeInd></gtr:leadResearchOrganisation><gtr:organisationRoles><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/3EAE04CA-9D62-4483-B9C4-F91AD9F4C5A9"><gtr:id>3EAE04CA-9D62-4483-B9C4-F91AD9F4C5A9</gtr:id><gtr:name>University of Oxford</gtr:name><gtr:address><gtr:line1>University Chest</gtr:line1><gtr:line2>Wellington Square</gtr:line2><gtr:line4>Oxford</gtr:line4><gtr:postCode>OX1 2JD</gtr:postCode><gtr:region>South East</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>LEAD_RO</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/CF11C8EB-DE92-4FC8-8F5D-477390597C44"><gtr:id>CF11C8EB-DE92-4FC8-8F5D-477390597C44</gtr:id><gtr:name>McMaster University</gtr:name><gtr:address><gtr:line1>1280 Main Street West</gtr:line1><gtr:line4>Hamilton, Ontario</gtr:line4><gtr:line5>L8S 4L8</gtr:line5><gtr:region>Outside UK</gtr:region><gtr:country>Canada</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/51A751AB-38DA-40F0-9408-10E24875FEBA"><gtr:id>51A751AB-38DA-40F0-9408-10E24875FEBA</gtr:id><gtr:name>Christchurch Hospital</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/4A179E2C-FB5E-4836-AA80-6301F4DD5AB6"><gtr:id>4A179E2C-FB5E-4836-AA80-6301F4DD5AB6</gtr:id><gtr:name>University of Sydney</gtr:name><gtr:address><gtr:line1>University of Sydney</gtr:line1><gtr:region>Outside UK</gtr:region><gtr:country>Australia</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/1DED8BE4-FAAC-4D4F-B5D8-20D587078DF4"><gtr:id>1DED8BE4-FAAC-4D4F-B5D8-20D587078DF4</gtr:id><gtr:name>Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole></gtr:organisationRoles><gtr:personRoles><gtr:personRole url="http://gtr.ukri.org:80/person/7E869C42-6A45-45B9-9699-CDF1916D188C"><gtr:id>7E869C42-6A45-45B9-9699-CDF1916D188C</gtr:id><gtr:firstName>Edmund</gtr:firstName><gtr:surname>Hey</gtr:surname><gtr:roles><gtr:role><gtr:name>CO_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.ukri.org:80/person/02E446DE-298E-4426-8FAF-CA965B79597F"><gtr:id>02E446DE-298E-4426-8FAF-CA965B79597F</gtr:id><gtr:firstName>Henry</gtr:firstName><gtr:surname>Halliday</gtr:surname><gtr:roles><gtr:role><gtr:name>CO_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.ukri.org:80/person/8F4191DC-98B5-4C58-89B3-8C4C67CBBFC2"><gtr:id>8F4191DC-98B5-4C58-89B3-8C4C67CBBFC2</gtr:id><gtr:firstName>Peter</gtr:firstName><gtr:surname>Brocklehurst</gtr:surname><gtr:roles><gtr:role><gtr:name>PRINCIPAL_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.ukri.org:80/person/D731AB69-BB05-4923-A3E7-42620B999379"><gtr:id>D731AB69-BB05-4923-A3E7-42620B999379</gtr:id><gtr:firstName>Sanjeev</gtr:firstName><gtr:surname>Deshpande</gtr:surname><gtr:roles><gtr:role><gtr:name>CO_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.ukri.org:80/person/8DE7CBE5-5B3F-4C4F-9DAE-6D8097EDFE0A"><gtr:id>8DE7CBE5-5B3F-4C4F-9DAE-6D8097EDFE0A</gtr:id><gtr:firstName>Win</gtr:firstName><gtr:surname>Tin</gtr:surname><gtr:roles><gtr:role><gtr:name>CO_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.ukri.org:80/person/593A409A-4A2F-4FB4-BF35-B3DF034127AF"><gtr:id>593A409A-4A2F-4FB4-BF35-B3DF034127AF</gtr:id><gtr:firstName>Pamela</gtr:firstName><gtr:otherNames>Anne</gtr:otherNames><gtr:surname>Cairns</gtr:surname><gtr:roles><gtr:role><gtr:name>CO_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.ukri.org:80/person/7208400B-6791-4400-A90A-059F08720740"><gtr:id>7208400B-6791-4400-A90A-059F08720740</gtr:id><gtr:firstName>Neil</gtr:firstName><gtr:surname>Marlow</gtr:surname><gtr:roles><gtr:role><gtr:name>CO_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.ukri.org:80/person/B3416C25-79BB-40B9-8A12-1679A5C5149A"><gtr:id>B3416C25-79BB-40B9-8A12-1679A5C5149A</gtr:id><gtr:firstName>Benjamin</gtr:firstName><gtr:otherNames>James</gtr:otherNames><gtr:surname>Stenson</gtr:surname><gtr:roles><gtr:role><gtr:name>CO_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole></gtr:personRoles><gtr:project url="http://gtr.ukri.org:80/projects?ref=G0400415"><gtr:id>E80C5B4F-22C1-4FFD-9A57-8D6840CAAF59</gtr:id><gtr:title>Which oxygen saturation level should we use for very premature infants? A randomised controlled trial (BOOST -II UK)</gtr:title><gtr:status>Closed</gtr:status><gtr:grantCategory>Research Grant</gtr:grantCategory><gtr:grantReference>G0400415</gtr:grantReference><gtr:abstractText>In the UK each year over three thousand babies are born more than 12 weeks premature. Two thirds of these very premature babies now survive, but most grow poorly and many have problems breathing. A quarter have at least one major disability at age two, and many have cerebral palsy. Most of these babies require oxygen therapy for several weeks after birth, but we know that giving babies very high levels of oxygen is toxic to the developing eye which may lead to surgery on the eye in order to try and prevent blindness. We do not know whether very preterm babies should only be given enough oxygen to maintain their levels a little above what it is in if they were still in the womb, or whether we should try and keep the their oxygen levels as high as a baby born at the usual time. If oxygen levels are kept low it is likely to prevent eye damage but it may lead to more deaths and may lead to other disabilities in this group of babies. Alternatively if the oxygen levels are kept high it may cause eye damage but prevent early deaths and other later disability. 

This randomised study will compare the effects of maintaining the babies oxygen level low (functional arterial oxygen saturations at 85?89%) versus high (functional arterial oxygen saturations at 91?95%) in babies born at less than 28 weeks gestation. The primary outcome for the trial is death and major disability at age 2 years. Secondary outcomes include retinal surgery for retinopathy of prematurity as well as duration of oxygen therapy, chronic lung disease, growth and health service utilisation. The trial will recruit 1,200 babies from 20 UK centres over a period of four years.</gtr:abstractText><gtr:technicalSummary>In the UK each year over three thousand babies are born more than 12 weeks premature. Two thirds of these very premature babies now survive to discharge, but most grow poorly and many have respiratory problems. A quarter have at least one major disability when seen for assessment two years later, and many have cerebral palsy. Most of these babies require supplemental oxygen for several weeks after birth, but high arterial oxygen pressures are known to be toxic to the developing retina. We do not know whether very preterm babies should only be given enough oxygen to maintain arterial saturation a little above what it is in utero, or enough to achieve the saturations seen in the healthy term baby after birth. Observational studies suggest that rates of retinopathy of prematurity correlate with differing attitudes towards early oxygen use. However restricting oxygen exposure to minimise this problem risks increasing early mortality, the number of survivors with cerebral palsy, and cognitive ability in the long term survivors. This double blind randomised controlled trial will compare the effects of maintaining functional arterial oxygen saturations at levels of 85?89% versus 91?95% in babies born at less than 28 weeks gestation. The primary outcome for the trial is mortality and major disability at age 2 years. Secondary outcomes include retinal surgery for retinopathy of prematurity as well as duration of oxygen therapy, chronic lung disease, growth and health service utilisation. The trial will recruit 1,200 babies from 20 UK centres over a period of four years.</gtr:technicalSummary><gtr:fund><gtr:end>2009-12-31</gtr:end><gtr:funder url="http://gtr.ukri.org:80/organisation/C008C651-F5B0-4859-A334-5F574AB6B57C"><gtr:id>C008C651-F5B0-4859-A334-5F574AB6B57C</gtr:id><gtr:name>MRC</gtr:name></gtr:funder><gtr:start>2006-06-01</gtr:start><gtr:type>INCOME_ACTUAL</gtr:type><gtr:valuePounds>2418128</gtr:valuePounds></gtr:fund><gtr:output><gtr:artisticAndCreativeProductOutputs/><gtr:collaborationOutputs><gtr:collaborationOutput><gtr:collaboratingOrganisation>McMaster University</gtr:collaboratingOrganisation><gtr:country>Canada</gtr:country><gtr:department>Canadian Oxygen Trial (COT)</gtr:department><gtr:description>NeOProM: Neonatal Oxygenation Prospective Meta-analysis</gtr:description><gtr:id>CC3165BE-C3EC-460C-940A-58190943C6A7</gtr:id><gtr:impact>21235822 NeOProM: Neonatal Oxygenation Prospective Meta-analysis Collaboration study protocol BMC Pediatrics , 11 , Article 6. 10.1186/1471-2431-11-6.</gtr:impact><gtr:outcomeId>rx3NvHsz28x-3</gtr:outcomeId><gtr:partnerContribution>Each study will have independent responsibility for the recruitment and follow-up of babies in their country. Each trial will first publish their respective results as they become available and the combined meta-analytic results, using individual patient data, will be published when all trials are complete. The methodology to be used will provide the same strengths as a single large-scale multicentre randomised study whilst allowing greater pragmatic flexibility.</gtr:partnerContribution><gtr:piContribution>BOOST-II UK are responsible for the recruitment and follow-up of babies in the UK and Ireland. BOOST-II UK will publish their trial results independently of the NeOProM collaboration. Data from all studies will also be combined to enable a prospective meta-analysis to be performed.</gtr:piContribution><gtr:sector>Academic/University</gtr:sector></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)</gtr:collaboratingOrganisation><gtr:country>United States of America</gtr:country><gtr:department>Neonatal Research Network</gtr:department><gtr:description>NeOProM: Neonatal Oxygenation Prospective Meta-analysis</gtr:description><gtr:id>526E2417-22A0-4017-9A83-5815FCE62782</gtr:id><gtr:impact>21235822 NeOProM: Neonatal Oxygenation Prospective Meta-analysis Collaboration study protocol BMC Pediatrics , 11 , Article 6. 10.1186/1471-2431-11-6.</gtr:impact><gtr:outcomeId>rx3NvHsz28x-4</gtr:outcomeId><gtr:partnerContribution>Each study will have independent responsibility for the recruitment and follow-up of babies in their country. Each trial will first publish their respective results as they become available and the combined meta-analytic results, using individual patient data, will be published when all trials are complete. The methodology to be used will provide the same strengths as a single large-scale multicentre randomised study whilst allowing greater pragmatic flexibility.</gtr:partnerContribution><gtr:piContribution>BOOST-II UK are responsible for the recruitment and follow-up of babies in the UK and Ireland. BOOST-II UK will publish their trial results independently of the NeOProM collaboration. Data from all studies will also be combined to enable a prospective meta-analysis to be performed.</gtr:piContribution><gtr:sector>Charity/Non Profit</gtr:sector></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University of Sydney</gtr:collaboratingOrganisation><gtr:country>Australia, Commonwealth of</gtr:country><gtr:department>NHMRC Clinical Trials Centre</gtr:department><gtr:description>NeOProM: Neonatal Oxygenation Prospective Meta-analysis</gtr:description><gtr:id>6E055C17-8CBA-42B9-BF8B-B024830572F7</gtr:id><gtr:impact>21235822 NeOProM: Neonatal Oxygenation Prospective Meta-analysis Collaboration study protocol BMC Pediatrics , 11 , Article 6. 10.1186/1471-2431-11-6.</gtr:impact><gtr:outcomeId>rx3NvHsz28x-1</gtr:outcomeId><gtr:partnerContribution>Each study will have independent responsibility for the recruitment and follow-up of babies in their country. Each trial will first publish their respective results as they become available and the combined meta-analytic results, using individual patient data, will be published when all trials are complete. The methodology to be used will provide the same strengths as a single large-scale multicentre randomised study whilst allowing greater pragmatic flexibility.</gtr:partnerContribution><gtr:piContribution>BOOST-II UK are responsible for the recruitment and follow-up of babies in the UK and Ireland. BOOST-II UK will publish their trial results independently of the NeOProM collaboration. Data from all studies will also be combined to enable a prospective meta-analysis to be performed.</gtr:piContribution><gtr:sector>Academic/University</gtr:sector></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Christchurch Hospital</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:description>NeOProM: Neonatal Oxygenation Prospective Meta-analysis</gtr:description><gtr:id>A9B204E9-6901-489A-B080-C6DBCD502C31</gtr:id><gtr:impact>21235822 NeOProM: Neonatal Oxygenation Prospective Meta-analysis Collaboration study protocol BMC Pediatrics , 11 , Article 6. 10.1186/1471-2431-11-6.</gtr:impact><gtr:outcomeId>rx3NvHsz28x-2</gtr:outcomeId><gtr:partnerContribution>Each study will have independent responsibility for the recruitment and follow-up of babies in their country. Each trial will first publish their respective results as they become available and the combined meta-analytic results, using individual patient data, will be published when all trials are complete. The methodology to be used will provide the same strengths as a single large-scale multicentre randomised study whilst allowing greater pragmatic flexibility.</gtr:partnerContribution><gtr:piContribution>BOOST-II UK are responsible for the recruitment and follow-up of babies in the UK and Ireland. BOOST-II UK will publish their trial results independently of the NeOProM collaboration. Data from all studies will also be combined to enable a prospective meta-analysis to be performed.</gtr:piContribution><gtr:sector>Hospitals</gtr:sector></gtr:collaborationOutput></gtr:collaborationOutputs><gtr:disseminationOutputs><gtr:disseminationOutput><gtr:description>xStudy Update to Parents and Hospitals in The New England Journal of Medicine 364, 17, 1680-2</gtr:description><gtr:form>A magazine, newsletter or online publication</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>B350EDD5-1A44-4B00-9336-5305427CD9F3</gtr:id><gtr:impact>A study update was circulated to parents of all babies enrolled onto the study and all hospitals involved in BOOST-II, in April 2011 which gave a brief summary of why recruitment was closed early and advised of the publication of the paper by Dr Ben Stenson, Increased 36-week survival with high oxygen saturation target in extremely preterm infants, in The New England journal of medicine 364, 17, 1680-2

Minimal contact was received from parents, two parents of surviving babies rang to thank us for the information and for the opportunity to take part in the study, one bereaved family rang to request no more information and a number of bereaved parents responded by post to confirm they would like further updates as they become available.</gtr:impact><gtr:outcomeId>nVN9X8DFVeW</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Participants in your research and patient groups</gtr:primaryAudience><gtr:year>2011</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>xStudy Update to Parents &amp; Recruiting Centres in New England Journal of Medicine</gtr:description><gtr:form>A magazine, newsletter or online publication</gtr:form><gtr:geographicReach>National</gtr:geographicReach><gtr:id>DF1D2F2E-4463-4E09-968F-89733505E1A0</gtr:id><gtr:impact>Parents and recruiting centres were sent a study update in May 2013, to notify them that Short-term Outcome results had been published in the new England Journal of Medicine. The update gave a summary of the results and details of where the full publication could be accessed.

Minimal responses from parents were received with two bereaved families requesting that no further study updates be sent.</gtr:impact><gtr:outcomeId>V7YWkG1Lz7m</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Participants in your research and patient groups</gtr:primaryAudience><gtr:year>2013</gtr:year></gtr:disseminationOutput></gtr:disseminationOutputs><gtr:exploitationOutputs/><gtr:furtherFundingOutputs><gtr:furtherFundingOutput><gtr:amountPounds>28000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Major Ophthalmology Project Grant Year 3</gtr:description><gtr:end>2012-03-02</gtr:end><gtr:fundingOrg>The Royal College of Surgeons of Edinburgh</gtr:fundingOrg><gtr:id>4D42E1C1-B671-4E42-A457-E7AB25A64810</gtr:id><gtr:outcomeId>Zk4hqJHfVR60</gtr:outcomeId><gtr:sector>Learned Society</gtr:sector><gtr:start>2011-04-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>45000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Major Ophthalmology Project Grant Year 1</gtr:description><gtr:end>2010-03-02</gtr:end><gtr:fundingOrg>The Royal College of Surgeons of Edinburgh</gtr:fundingOrg><gtr:id>F10BBBE3-92F7-4185-B6EF-F2EBD5EE0ADF</gtr:id><gtr:outcomeId>188789B26FF0</gtr:outcomeId><gtr:sector>Learned Society</gtr:sector><gtr:start>2009-04-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>45000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Major Ophthalmology Project Grant Year 2</gtr:description><gtr:end>2011-03-02</gtr:end><gtr:fundingOrg>The Royal College of Surgeons of Edinburgh</gtr:fundingOrg><gtr:id>B1EB4CCC-EF57-4A7D-B222-5818C44222DA</gtr:id><gtr:outcomeId>NyjyHNDiijn0</gtr:outcomeId><gtr:sector>Learned Society</gtr:sector><gtr:start>2010-04-01</gtr:start></gtr:furtherFundingOutput></gtr:furtherFundingOutputs><gtr:impactSummaryOutputs/><gtr:intellectualPropertyOutputs/><gtr:otherResearchOutputs/><gtr:policyInfluenceOutputs><gtr:policyInfluenceOutput><gtr:areas/><gtr:description>Changes to Oxygen Saturation Targets for extremely Pre-Term Infants at individual Neonatal Units</gtr:description><gtr:geographicReach>Multiple continents/international</gtr:geographicReach><gtr:id>D639D857-DB75-4020-8210-79F29140252F</gtr:id><gtr:impact>Following the announcement of increased survival of infants receiving the higher saturation targets a number of hospitals have already amended their oxygen target ranges for very premature infants, to avoid targeting too low. The information given has always been that these are very early findings and that further information from the final study data is required before any clear guidance can be given. Many other neonatal units have therefore made no or only minor changes to their target ranges and are keenly awaiting further information from the forthcoming short-term results paper planned for early 2012 and the final paper due late 2013.</gtr:impact><gtr:outcomeId>VTurB6m6LUN</gtr:outcomeId><gtr:type>Influenced training of practitioners or researchers</gtr:type></gtr:policyInfluenceOutput></gtr:policyInfluenceOutputs><gtr:productOutputs/><gtr:researchDatabaseAndModelOutputs/><gtr:researchMaterialOutputs/><gtr:softwareAndTechnicalProductOutputs/><gtr:spinOutOutputs/></gtr:output><gtr:publications><gtr:publication><gtr:id>50D2B4A4-6ED5-4699-BA59-4B62584C4085</gtr:id><gtr:title>Increased 36-week survival with high oxygen saturation target in extremely preterm infants.</gtr:title><gtr:parentPublicationTitle>The New England journal of medicine</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/e5df6c71e477bbc6be262f77df83e020"><gtr:id>e5df6c71e477bbc6be262f77df83e020</gtr:id><gtr:otherNames>Stenson B</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>0028-4793</gtr:issn><gtr:outcomeId>rkWsrZQYYDs</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>5DDD496A-D5D2-4BCE-94CF-61A9CB1FE38B</gtr:id><gtr:title>Outcomes of Two Trials of Oxygen-Saturation Targets in Preterm Infants.</gtr:title><gtr:parentPublicationTitle>The New England journal of medicine</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/5f2794d67ef790c999ac3f6988fc50dd"><gtr:id>5f2794d67ef790c999ac3f6988fc50dd</gtr:id><gtr:otherNames>BOOST-II Australia and United Kingdom Collaborative Groups</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>0028-4793</gtr:issn><gtr:outcomeId>56d44ad296b8d2.42368224</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>9DFB058B-6B1B-4446-B3F2-E7B51140AACB</gtr:id><gtr:title>The effect of oxygen saturation targeting on retinal blood vessel growth using retinal image data from the BOOST-II UK Trial.</gtr:title><gtr:parentPublicationTitle>Eye (London, England)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/7940f2f15e7bd4d58158f36ad4442a9d"><gtr:id>7940f2f15e7bd4d58158f36ad4442a9d</gtr:id><gtr:otherNames>Moreton RB</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>0950-222X</gtr:issn><gtr:outcomeId>56d44a89259450.91271969</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>A36139D3-9C35-4E27-AA13-124DC34DD577</gtr:id><gtr:title>Oxygen saturation and outcomes in preterm infants.</gtr:title><gtr:parentPublicationTitle>The New England journal of medicine</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/b41721d73d6b68176b38f5acebff18ba"><gtr:id>b41721d73d6b68176b38f5acebff18ba</gtr:id><gtr:otherNames>BOOST II United Kingdom Collaborative Group</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>0028-4793</gtr:issn><gtr:outcomeId>pm_12795_25_23642047</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>500F6400-47C9-4F8B-ACEA-F7A6061B5ABA</gtr:id><gtr:title>Oxygen targeting in preterm infants using the Masimo SET Radical pulse oximeter.</gtr:title><gtr:parentPublicationTitle>Archives of disease in childhood. Fetal and neonatal edition</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/2408b349225b396eaf0b081b163e1e89"><gtr:id>2408b349225b396eaf0b081b163e1e89</gtr:id><gtr:otherNames>Johnston ED</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>1359-2998</gtr:issn><gtr:outcomeId>nerF3sd1Dig</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>71E78EEE-85D8-43F6-A326-ADB3AE5E24CF</gtr:id><gtr:title>NeOProM: Neonatal Oxygenation Prospective Meta-analysis Collaboration study protocol.</gtr:title><gtr:parentPublicationTitle>BMC pediatrics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/51745a911dc9ecd1f48fca348ed3b6f7"><gtr:id>51745a911dc9ecd1f48fca348ed3b6f7</gtr:id><gtr:otherNames>Askie LM</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>1471-2431</gtr:issn><gtr:outcomeId>dojHcXEXjWy</gtr:outcomeId></gtr:publication></gtr:publications><gtr:identifiers><gtr:identifier type="RCUK">G0400415</gtr:identifier></gtr:identifiers><gtr:healthCategories><gtr:healthCategory><gtr:id>FA7AA693-7EDD-4A7E-8CA3-6B5658FBF717</gtr:id><gtr:percentage>100</gtr:percentage><gtr:text>Reproductive Health and Childbirth</gtr:text></gtr:healthCategory></gtr:healthCategories><gtr:researchActivities><gtr:researchActivity><gtr:id>74DC189C-F240-42D1-84DD-85475A95ABE8</gtr:id><gtr:percentage>100</gtr:percentage><gtr:text>6.7  Physical</gtr:text></gtr:researchActivity></gtr:researchActivities><gtr:researchSubjects/><gtr:researchTopics/><gtr:rcukProgrammes/></gtr:project></gtr:projectComposition></gtr:projectOverview>